Výsledky vyhledávání - "hormone deprivation therapy"

Akademický článek

Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of WHO fracture risk assessment tool (FRAX) and bone mineral density in real-life clinical practice

Autor: Gherardo Mazziotti, Walter Vena, Rebecca Pedersini, Sara Piccini, Emanuela Morenghi, Deborah Cosentini, Paolo Zucali, Rosalba Torrisi, Silvio Sporeni, Edda L. Simoncini, Roberto Maroldi, Luca Balzarini, Andrea G. Lania, Alfredo Berruti

Publikováno v: Journal of Bone Oncology, Vol 33, Iss , Pp 100421- (2022)

Background and Objective: Prediction of fractures in cancer survivors exposed to hormone-deprivation therapies (HDTs) is a challenge since bone loss is rapid and severe, and determinants of fractures in this setting are still largely unknown. In this

Externí odkaz: https://doaj.org/article/ef3dbe48af154edd868ecf7a3bd515b1

Zobrazit plný text záznamu

Bone loss induced by cancer treatments in breast and prostate cancer patients

Autor: Santos Castañeda, Ana Casas, Aránzazu González-del-Alba, Guillermo Martínez-Díaz-Guerra, Xavier Nogués, Cristina Ojeda Thies, Óscar Torregrosa Suau, Álvaro Rodríguez-Lescure

Publikováno v: Clinical and Translational Oncology. 24:2090-2106

Cancer and cancer therapies are a major factor risk for osteoporosis due to bone loss and deterioration of bone microarchitecture. Both factors contribute to a decrease in bone strength and, consequently, increased bone fragility and risk of fracture

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::380cbee03b44f957425ad21394a0c823
https://doi.org/10.1007/s12094-022-02872-1

Zobrazit plný text záznamu

Bone loss induced by cancer treatments in breast and prostate cancer patients

Autor: Castañeda S, Casas A, González-Del-Alba A, Martínez-Díaz-Guerra G, Nogués X, Ojeda Thies C, Torregrosa Suau Ó, Rodríguez-Lescure Á

Publikováno v: CLINICAL & TRANSLATIONAL ONCOLOGY
r-FISABIO. Repositorio Institucional de Producción Científica
instname

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::4ca4e6ee85c660a21c7362c91c9b4e19
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13784

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Explaining hormone-deprivation therapy failure in prostate cancer patients

Autor: Jun Luo

Publikováno v: Expert review of endocrinologymetabolism. 4(2)

In 1941, Huggins and Hodges demonstrated the clinical efficacy of hormonal manipulation for the treatment of metastatic prostate cancer [1]. Hormone deprivation therapies employing surgical and/or ...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc4deef3203455a1cca132b481a99f64
https://pubmed.ncbi.nlm.nih.gov/30780850

Zobrazit plný text záznamu

Intermittent androgen deprivation therapy: recommendations to improve the management of patients with prostate cancer following the GRADE approach

Autor: Bonfill, X, Arevalo-Rodriguez, I, Garcia, LM, Quintana, MJ, Buitrago-Garcia, D, Urbina, DL, Cordero, JA, IADT Spanish Study Grp

Publikováno v: Cancer Management and Research
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Purpose: The purpose of this study was to provide evidence-based recommendations of intermittent androgen deprivation therapy (IADT) compared with continuous androgen deprivation therapy (CADT) for men with prostate cancer (PCA). Methods: We conducte

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::21406c10a440888355daba8bc017c80f
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4055

Zobrazit plný text záznamu

Intermittent androgen deprivation therapy: recommendations to improve the management of patients with prostate cancer following the GRADE approach

Autor: María Jesús Quintana, Diego Lobos Urbina, Diana Buitrago-Garcia, Laura Martínez García, Ingrid Arevalo-Rodriguez, Xavier Bonfill, José Antonio Cordero

Publikováno v: RECERCAT (Dipòsit de la Recerca de Catalunya)
Recercat. Dipósit de la Recerca de Catalunya
instname
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Cancer Management and Research

Xavier Bonfill,1–3 Ingrid Arevalo-Rodriguez,4,5 Laura Martínez García,3 Maria Jesús Quintana,1,2 Diana Buitrago-Garcia,4 Diego Lobos Urbina,6 José Antonio Cordero7 On behalf of the IADT Spanish Study Group 1Department of Clinical Epidemiology a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cbb6fdea498e1f4bc2f077acb21a0ae
http://hdl.handle.net/2072/357250

Zobrazit plný text záznamu

Influence of cardiovascular (CV) comorbidities on the selection of hormone deprivation therapy (HDT) in the treatment of metastatic prostate cancer (mPCa)

Autor: Michael Gedamke, Sebastian Vosgerau, Markus Flesch, Jan Lehmann

Publikováno v: Journal of Clinical Oncology. 36:TPS392-TPS392

TPS392 Background: HDT with LHRH agonists (LHRH) or LHRH-antagonists (degarelix, D) is the standard of care in advanced mPCa. A correlation between leuprolide/goserelin and an increased risk of CV events as compared to D has been shown in a pooled an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1b5abce048267b580528e63e31f6823e
https://doi.org/10.1200/jco.2018.36.6_suppl.tps392

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání